Analysen von Mark Purcell
| 04.08.14 | AstraZeneca neutral | Barclays Capital | |
| 29.07.14 | GSK Equal weight | Barclays Capital | |
| 25.07.14 | Roche overweight | Barclays Capital | |
| 21.07.14 | Novartis Equal weight | Barclays Capital | |
| 14.07.14 | STADA Underweight | Barclays Capital | |
| 14.07.14 | Bayer Equal weight | Barclays Capital | |
| 14.07.14 | Merck Underweight | Barclays Capital | |
| 02.07.14 | Bristol-Myers Squibb Equal weight | Barclays Capital | |
|
Werbung
|
|||
| 02.07.14 | Johnson Johnson Equal weight | Barclays Capital | |
| 02.07.14 | Eli Lilly Equal weight | Barclays Capital | |
| 02.07.14 | Pfizer Equal weight | Barclays Capital | |
| 09.06.14 | Novartis Equal weight | Barclays Capital | |
| 21.05.14 | AstraZeneca Equal weight | Barclays Capital | |
| 23.04.14 | Novartis Underweight | Barclays Capital | |
| 16.04.14 | Roche overweight | Barclays Capital | |
| 14.04.14 | Bayer Equal weight | Barclays Capital | |
| 14.04.14 | STADA Underweight | Barclays Capital | |
| 14.04.14 | Merck Underweight | Barclays Capital | |
| 10.03.14 | STADA Underweight | Barclays Capital | |
| 10.03.14 | Bayer Equal weight | Barclays Capital | |
| 10.03.14 | AstraZeneca neutral | Barclays Capital | |
| 10.03.14 | GSK Equal weight | Barclays Capital | |
| 10.03.14 | Novartis Underweight | Barclays Capital | |
| 10.03.14 | Sanofi overweight | Barclays Capital | |
| 10.03.14 | Roche overweight | Barclays Capital | |
| 10.03.14 | Merck Underweight | Barclays Capital | |
| 28.07.11 | GSK overweight | Barclays Capital | |